Clinical Trial Update: Exercise Induced Bronchoconstriction (0476-359) [Phase 1]

View source ↗

Summary

Phase 1 trial update for a program addressing exercise-induced bronchoconstriction in asthma; the Organon-sponsored study (identifier 0476-359) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction

Snippet

Sponsor: Organon and Co | Conditions: Asthma, Exercise-induced | Phase 1 | Status: COMPLETED